Veracyte (VCYT) Tops Q1 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. JBHT
3. CRWV
4. TFC
5. NEST:IN
6. AA
7. SCHW
8. TECHM:IN
9. POLYCAB:IN
10. MSCI

Go back to Veracyte (VCYT) Tops Q1 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus

Veracyte Announces First Quarter 2019 Financial Results

April 30, 2019 4:15 PM EDT

Grew Revenue by 47% to $29.5 Million

Grew Genomic Test Volume by 33% to 9,162 Tests

Company Raises 2019 Annual Revenue Guidance

Conference Call and Webcast Today at 5:00 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced financial results for the first quarter ended March 31, 2019 and provided an update on recent business progress.

We delivered excellent results in the first quarter of 2019, said Bonnie Anderson, chairman and chief executive officer of Veracyte.... More